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تكرار التعدد اجليين ملورثات Arg16Gly, Gln27Glu and Thr164Ile يف 
مستقبالت بيتا 2 األدرينريجية عند العمانيني
خالد البلو�سي، فهد الزدجايل، �سو�سن ال�سنانية، املعت�سم الزدجايل، ريا�ض بيومي
abstract: Objectives: This study aimed to assess the distribution of missense mutations in the adrenoceptor 
β2 (ADRB2) gene in an Omani cohort. Methods: This study was carried out between May 2014 and March 2015 
at the Sultan Qaboos University, Muscat, Oman. Blood samples were taken from 316 unrelated Omani subjects. 
Genotyping for rs1042713 (c.46A>G, p.Arg16Gly), rs1042714 (c.79C>G, p.Gln27Glu) and rs1800888 (c.491C>T, 
p.Thr164Ile) polymorphisms was performed by real-time polymerase chain reaction using single nucleotide 
polymorphism (SNP) genotyping assays. The allelic frequencies of these polymorphisms were estimated on 
the basis of the observed numbers of specific alleles from the genotype data for male and female subjects. The 
genotype frequencies for each polymorphism were tested for deviation from the Hardy-Weinberg equilibrium. 
Results: Gly16 and Glu27 were the most frequent variants found among the cohort (63% and 75%, respectively). 
The Ile164 variant was not detected in the study population. There was a significant linkage disequilibrium between 
the rs1042713 and rs1042714 SNPs (r2 = 0.209; P ≤0.001). The most observed haplotypes were Gly16-Gln27 and 
Arg16-Gln27 (0.37 and 0.38, respectively). The frequency of Gly16-Glu27 was 0.25, comprising all Glu27 carriers. 
Conclusion: The allelic distribution of variants in this Omani cohort was similar to distributions reported among 
Caucasian populations. 
Keywords: beta-2 Adrenergic Receptor; Genetic Polymorphisms; Single Nucleotide Polymorphisms; Allele Freq-
uencies; Genotype; Oman.
امللخ�ص: الهدف: هدف هذا البحث اإىل درا�سة توزيع الطفرات املغلطة يف مورثات م�ستقبالت بيتا 2 الأدرينريجية )ADRB2( يف جمموعة 
من العمانيني. الطريقة: اأجريت الدرا�سة بني مايو 2014م ومار�ض 2015م بجامعة ال�سلطان قابو�ض مب�سقط يف عمان. متجمع عينات دم من 
 p.Gln27Glu( ،rs1042713 )c.46A<G, p.Arg16Gly( 316 فرد من العمانيني الغري اأقارب. ومتت درا�سة منط التعدد اجليني يف مورثات
احلقيقي(  )الوقت  الت�سل�سلي  البلمرة  تفاعل  جهاز  بوا�سطة   rs1800888  )c.491C<T,  p.Thr164Ile(  and  rs1042714  )c.79C<G,
وبا�ستخدام مقاي�سة التنميط اجليني للتعدد اجليني للنيوكليوتايد الواحد )SNP(. ومت تقدير هذه التعددات اجلينية بح�سب الأرقام املالحظة 
انحراف  البحث. وقي�ض  الذكور والإناث يف هذا  الأمناط اجلينية يف عينات  الأليات املحددة املتح�سل عليها من معلومات  من تعدادات 
تكراركل تعدد جيني من توازن هاردي–فاينبريغ. النتائج: كانت اأكرث املتفاوتات تكرارا هي Gly16 و Glu27 يف املجموعة التي متت 
درا�ستها %63 و%75، على التوايل(. ومل يوجد متفاوت Ile164 يف تلك املجموعة. وكان هنالك اختالل توازن معنوي اإح�سائيا يف الرتباط 
 0.37( Arg16-Gln27 و Gly16-Gln27 وكان اأكرث منط فرداين هو يف .rs1042713 و rs1042714 SNPs )r2 = 0.209 ; P ≤0.001( بني ال
و 0.38 على التوايل(. وبلغ تواتر Gly16-Glu27 0.25، وي�سمل ذلك حوامل Glu27. اخلال�صة: كان التوزيع الأليلي ملختلف املتفاوتات يف 
املجموعة العمانية التي در�ست م�سابهة لتوزيعها عند ال�سعوب القوقازية.
مفتاح الكلمات: م�ستقبالت بيتا 2 الأدرينريجية؛ التعدد اجليني؛ التعدد اجليني للنيككليوتايد الواحد؛ تكرارالأليات؛ النمط اجليني؛ عمان.
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Advances in Knowledge 
- This study explores the distribution of the major missense mutations of the adrenoceptor β2 (ADRB2) gene in the Omani population.
- The p.Arg16Gly and p.Gln27Glu variants occurred most frequently among this Omani cohort.
Application to Patient Care
- Variations in the ADRB2 gene can affect responses to drug actions, thereby impacting diseases in which ADRB2 plays a role, such 
as asthma, obesity and hypertension. The results of this study could therefore be of importance for the clinical management of 
these diseases. 
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Genetic variation in the human β2-adrenergic receptor (β2AR) has been the subject of much experimental and 
pharmacoclinical research, especially in the treatment 
of asthma. Initially cloned, sequenced and reported 
by Kobilka et al., β2AR encodes a 413 amino acid 
protein belonging to the family of G-protein coupled 
receptors.1 The receptor is the product of the 1,242-
base pair intronless adrenoceptor β2 (ADRB2) gene 
located on the long arm of chromosome 5 (q31.q32).1 
ADRB2 has been linked to asthma, asthma-related 
phenotypes and diseases such as hypertension and 
obesity.2–5 β2AR is expressed in different types of cells 
in the lung, including airway smooth muscle cells, the 
vascular endothelium, alveolar walls, immune cells 
and presynaptic cholinergic nerve terminals.6
Reihsaus et al. described nine single nucleotide 
polymorphisms (SNPs) in the coding region of 
ADRB2.7 Four of these SNPs were nonsynonymous 
mutations leading to changes in the amino acid 
sequence: rs1042713 (c.46A>G, p.Arg16Gly), rs104- 
2714 (c.79C>G, p.Gln27Glu), rs1800888 (c.491C>T, 
p.Thr164Ile) and rs1141370 (c.100G>A, p.Val34Met). 
The first three of the nonsynonymous SNPs de-
monstrated  in vivo functional effects on the receptor 
activity.7 The rs1800888 and rs1141370 SNPs were 
infrequent and found only in the heterozygous state. 
Arg16Gly and Glyn27Glu were the most common 
nonsynonymous polymorphisms reported in the 
ADRB2 gene.7 The Arg16Gly polymorphism is the 
most common and functionally relevant SNP at 
the amino terminus of the receptor; it occurs with 
allelic frequencies of between 67–72% in different 
populations.8 The frequency of the Gln27Glu 
polymorphism is approximately 29% in Caucasian 
populations.7 The Thr164Ile polymorphism, which is 
located in the fourth transmembrane domain of β2AR, 
exhibits an allelic frequency of 2–5% in Caucasian 
populations; however, it has only been reported in the 
heterozygous state so far.7
Allelic frequencies of ADRB2 polymorphisms, 
especially the SNPs in the coding region, have been 
studied in different ethnic groups. Studies on African 
American, European American, Saudi, Southwest 
Asian, Kenyan and Chinese populations all show 
inter-ethnic variation in the frequency of Gln27Glu 
and Arg16Gly polymorphisms.9,10 Since β2AR is 
an important target for many asthma drugs, these 
variations in the frequency of ADRB2 genotypes may 
influence disease susceptibility and drug responses 
in different populations.11 Jamil et al. reported that 
the prevalence of asthma in the USA was lower 
among Arabs in comparison to non-Middle Eastern 
Caucasians, independent of environmental factors.12 
This further suggests the role of ethnic-specific 
gene-environment interactions in the predisposition 
to asthma. Therefore, the current study aimed to 
determine the frequencies of alleles and haplotypes of 
major missense mutations in the ADRB2 gene in an 
Omani cohort.
Methods
This study was carried out between May 2014 and 
March 2015 at the Sultan Qaboos University (SQU), 
Muscat, Oman. A total of 316 unrelated Omani 
subjects were recruited either as volunteers from 
the community or from patients visiting the Family 
Medicine & Community Clinic at SQU Hospital for 
regular medical check-ups. The inclusion criteria for 
the subjects were Omani nationality and an age of 
≥35 years old. A minimum sample size of 261 was 
calculated based on 5.5% precision, 5% type I error and 
the reported proportion of Gln27Glu in a Caucasian 
population (0.29).8
Blood was collected from all participants for the 
purposes of DNA extraction. Genomic DNA was 
isolated from 200 µL of whole blood using a DNA kit 
(QIAGEN GmbH, Hilden, Germany) according to the 
protocols provided by the manufacturer. Genotyping 
for the rs1042713, rs1042714 and rs1800888 SNPs was 
performed by real-time polymerase chain reaction using 
SNP genotyping assays (TaqMan®, Applied Biosystems, 
Thermo Fisher Scientific Inc., Wilmington, Delaware, 
USA) according to the manufacturer’s instructions. 
Statistical analyses were performed using the 
Statistical Package for the Social Sciences (SPSS), 
Version 20.0 (IBM Corp., Chicago, Illinois, USA). Data 
were compiled by genotype and the derived allelic 
frequencies were estimated based on the observed 
numbers of the specific alleles from the genotype data 
for male and female subjects. The genotype frequencies 
for each polymorphism were tested for deviation from 
the Hardy-Weinberg equilibrium (HWE) using a 
Chi-squared goodness-of-fit analysis with one degree 
of freedom. Haplotypes were constructed from the 
combination of both polymorphisms. Frequencies 
were inferred using PHASE 2.1.1 software (Matthew 
Stephens Laboratory, Department of Human Genetics, 
University of Chicago, Chicago, Illinois, USA).13,14
Ethical permission to conduct this study was 
obtained from the Medical Research & Ethics 
Committee of the College of Medicine & Health 
Sciences at SQU (MREC #284-A). All participants 
gave informed consent before inclusion in the study.
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Results
Among the Omani cohort, there were 129 male and 
187 female subjects. The overall mean age was 46.0 
± 8.0 years, with a mean age of 45.0 ± 9.0 years for 
males and 46.0 ± 7.9 years for females (P = 0.291). 
Three variants of the ADRB2 gene were genotyped: 
rs1042713 (p.Arg16Gly), rs1042714 (p.Gln27Glu) and 
rs1800888 (p.Thr164Ile). No significant differences 
were observed in the genotype frequencies between 
genders [Table 1]. The rare rs1800888 SNP was 
not detected in the cohort; all individuals were 
homozygous for the wild-type allele. Gly16 and 
Gln27 were the most frequent variants in the study 
population (63% and 75%, respectively), with average 
frequencies of 0.63 and 0.75, respectively [Table 2]. 
The P values for observed and expected genotype 
frequencies of the rs1042713 and rs1042714 SNPS 
were 0.171 and 0.708, respectively, with no deviation 
from the HWE distribution. Allelic frequencies 
for the rs1042713, rs1800888 and rs1042714 SNPs 
were 0.63/0.37, 1.00/0.00 and 0.75/0.25, respectively 
[Table 3].
There was a significant linkage disequilibrium 
between the rs1042713 and rs1042714 SNPs (R2 = 
0.209; P ≤0.001). Random segregation of alleles showed 
that the Arg16 allele did not occur together with Glu27, 
as shown in the distribution of the AG haplotype. The 
most observed haplotypes in the cohort were Gly16-
Gln27 (GC) and Arg16-Gln27 (AC) with frequencies 
of 0.38 and 0.37, respectively. The frequency of Gly16-
Glu27 (GG) was also common (0.25), comprising all 
Glu27 carriers [Table 4]. 
Table 1: Genotype distributions of adrenoceptor β2 genetic 
polymorphisms by gender among an Omani cohort (N = 
316)






GG 54 (41.9) 77 (41.2)
AG 56 (43.4) 80 (42.8)
AA 19 (14.7) 30 (16.0)
rs1800888 C>T -
CC 129 (100.0) 187 (100.0)
CT 0 (0.0) 0 (0.0)
TT 0 (0.0) 0 (0.0)
rs1042714 C>G 0.715
CC 70 (54.3) 109 (58.3)
CG 49 (38.0) 67 (35.8)
GG 10 (7.8) 11 (5.9)
SNP = single nucleotide polymorphism.
Table 2: Allelic frequencies and percentages of 
adrenoceptor β-2 genetic polymorphisms among an 




rs1042713 GA 0.63/0.37 63/37
rs1800888 CT 1.00/0.00 100/0
rs1042714 CG 0.75/0.25 75/25
Table 3: Observed and expected genotype distributions 
and allelic frequencies of the adrenoceptor β-2 gene among 
an Omani cohort (N = 316)
SNP n 
(%)
95% CI HWE P 
value
Observed Expected
















































SNP = single nucleotide polymorphism; CI = confidence interval; 
HWE = Hardy-Weinberg equilibrium.
Table 4: Haplotype frequencies and linkage disequilibrium 
pattern of adrenoceptor β-2 genetic polymorphisms 
(rs1042713/rs1042714) among an Omani cohort (N = 316)
Haplotype n Frequency Linkage
R2 χ2 P 
value
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Discussion 
In the current study, Gly16 and Gln27 were the most 
common alleles among the Omani cohort. There were 
no differences in the genotype frequencies between 
genders, suggesting random selection; this was further 
supported by the lack of deviation from the HWE 
distribution. Previous research in different populations 
has suggested inter-ethnic differences in ADRB2 gene 
polymorphisms. The allelic frequencies of two SNPs 
(rs1042713 and rs1042714) in the current Omani 
cohort were compared with those of various ethnic 
groups reported in the literature [Table 5].9,10,15–21 
Gly16 and Gln27 polymorphisms occur with high 
allelic frequency in Caucasian populations;7,8 the 
frequencies of Gly16 and Gln27 polymorphisms in 
the current Omani cohort were similar. However, 
regardless of population, the frequency of the Gln27 
variant showed higher inter-ethnic variation than the 
Gly16 variant (standard deviation: 0.14 versus 0.07). 
The haplotype distributions in the population of 
the current study were similar to those reported in 
a previous study of the Turkish population.15 There 
is strong linkage disequilibrium between SNPs in 
the ADRB2 gene since limited sets of haplotypes are 
observed in different ethnic groups. Drysdale et al. 
reported three common haplotypes in Caucasians 
and four common haplotypes in African Americans 
based on 13 ADRB2 SNPs.22 Examinations of the 
results of genetic association studies between 
ADRB2 and diseases like asthma should take into 
account differences in genotype frequencies between 
populations and the existence of the strong linkage 
disequilibrium between ADRB2 SNPs. 
Variations in the ADRB2 gene affect patient 
responses to drug actions; therefore, these variations 
could be of importance for the clinical management 
of diseases in which β2AR plays a role, such as asthma, 
obesity and hypertension. Inter-ethnic differences 
in this receptor have been proposed to explain 
differences in responses to drugs such as terbutaline, 
isoproterenol and albuterol.23
Conclusion
The present study provides further evidence of inter-
ethnic differences in ADRB2 gene polymorphisms. 
The allelic distribution of variants in this Omani 
population was similar to distributions reported in 
Caucasian populations. 
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Table 5: Comparative analysis of allelic frequencies of 
Gly16 (rs1042713) and Gln27 (rs1042714) polymorphisms 
in various ethnic groups reported in the literature
Author and 
year of study






Maxwell et al.9 
2005
Saudi 0.53 0.83 100
Maxwell et al.9 
2005
Ghanaian 0.47 0.90 100
Maxwell et al.9 
2005
Kenyan 0.43 0.91 100
Maxwell et al.9 
2005
Sudanese 0.57 0.84 52
Maxwell et al.9 
2005
Filipino 0.46 0.91 78
Maxwell et al.9 
2005
Chinese 0.41 0.93 99










Maxwell et al.9 
2005
Scottish 0.59 0.54 100
Kato et al.17 
2001
Japanese 0.51 0.93 1,681
Ehrenborg et 
al.18 2000
Swedish 0.59 0.62 180
Hall et al.19 
2006
British 0.64 0.55 8,018
Hamdy et al.16 
2002
Egyptians 0.43 0.76 240
Aynacioglu et 
al.15 1999
Turkish 0.60 0.68 104
Ramasy et al.20 
1999
Australian 0.54 0.60 332
Xie et al.10 1999 American 
Caucasian
0.62 0.58 212





Present study Omani 0.63 0.75 316
Mean of all 
populations 
± SD





SD = standard deviation.
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